Pediatric blood & cancer
Journal
Overview
publication venue for
-
Feasibility and acceptability of a parent-child intervention to improve step count in childhood cancer survivors exposed to cardiotoxic therapy: The STEP UP for FAMILIES Study.
2024
-
Ovarian function in female survivors of high-risk neuroblastoma.
2024
-
Does anti-HPA-1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?
2024
-
Longitudinal assessment of Leydig cell function in male survivors of childhood cancer.
2023
-
A quality improvement initiative standardizing premedication for blood product transfusions.
2023
-
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
2023
-
Position paper: The time for cooperative group study of ropeginterferon alfa-2b in young patients with myeloproliferative neoplasms is now.
2023
-
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
2023
-
Fertility assessment and treatment in adolescent and young adult cancer survivors.
2023
-
Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients.
2023
-
v-SYMPHONY career development series: A collaboration to enhance professional awareness for pediatric hematology oncology trainees.
2022
-
Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper..
70 Suppl 4.
2022
-
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
2022
-
Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
2022
-
Imaging of pediatric thyroid tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper..
70 Suppl 4.
2022
-
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma.
2022
-
Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention.
2022
-
Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up..
69.
2022
-
Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events.
2021
-
Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor..
69.
2021
-
KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up..
69.
2021
-
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force..
68.
2021
-
Pyruvate kinase deficiency in children..
68.
2021
-
COVID-19 has changed the way we think about training future pediatric hematologists/oncologists..
68.
2021
-
Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody..
68.
2021
-
General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study..
68.
2021
-
Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia..
68.
2020
-
COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City..
68.
2020
-
Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions..
68.
2020
-
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma..
67.
2020
-
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience..
67.
2020
-
Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update..
67.
2020
-
Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment..
67.
2020
-
Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience..
67.
2019
-
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma..
66.
2019
-
Utilization of integrative medicine differs by age among pediatric oncology patients..
66.
2019
-
Content review of pediatric ethics consultations at a cancer center..
66.
2019
-
Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis..
66.
2018
-
Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study..
65.
2018
-
Dose-escalation is needed for gross disease in high-risk neuroblastoma..
65.
2018
-
Nutritional risk factors predict severe acute graft-versus-host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation..
65.
2017
-
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma..
65.
2017
-
High birth prevalence of sickle cell disease in Northwestern Tanzania..
65.
2017
-
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis..
65.
2017
-
Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience..
64.
2017
-
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study..
64.
2017
-
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors..
64.
2016
-
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis..
64.
2016
-
Hepatocellular adenoma among adult survivors of childhood and young adult cancer..
64.
2016
-
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative..
64.
2016
-
A single-center experience with undifferentiated embryonal sarcoma of the liver..
63.
2016
-
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults..
63.
2016
-
Late Toxicities of Intensity-Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma..
63.
2016
-
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee..
63.
2016
-
Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center..
63.
2016
-
Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms..
63.
2016
-
Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors..
63.
2015
-
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group..
63.
2015
-
Identification of Discrete Prognostic Groups in Ewing Sarcoma..
63.
2015
-
Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma..
62.
2015
-
Extraneural metastases of medulloblastoma: desmoplastic variants may have prolonged survival..
62.
2014
-
Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)..
62.
2014
-
Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue..
62.
2014
-
Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma..
62.
2014
-
Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy..
62.
2014
-
Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT)..
62.
2014
-
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group..
62.
2014
-
Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy..
61.
2014
-
Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies..
61.
2014
-
Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma..
61.
2014
-
Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies..
61.
2014
-
Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making..
61.
2014
-
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study..
61.
2014
-
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia..
61.
2014
-
Neuroblastoma and pediatric delirium: a case series..
61.
2013
-
Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?.
61.
2013
-
Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors..
61.
2013
-
Thrombophilia testing in children: a 7 year experience..
61.
2013
-
Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study..
61.
2013
-
Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study..
61.
2013
-
Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia..
61.
2013
-
Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments..
61.
2013
-
Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation..
60.
2013
-
High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology Group..
60.
2013
-
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study..
61.
2013
-
Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases..
60.
2013
-
The palatability and tolerability of deferasirox taken with different beverages or foods..
60.
2013
-
Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea..
60.
2013
-
Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia..
60.
2013
-
Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma..
60.
2013
-
Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung..
60.
2012
-
Prevalence of vitamin D insufficiency in survivors of childhood cancer..
60.
2012
-
Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease..
60.
2012
-
Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience..
60.
2012
-
Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets..
59.
2012
-
Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report..
60.
2012
-
Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment..
59.
2012
-
Paroxysmal nocturnal hemoglobinuria in pediatric patients..
59.
2011
-
Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP)..
58.
2011
-
Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma..
58.
2011
-
Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group..
57.
2011
-
Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma..
57.
2011
-
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma..
58.
2011
-
Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study..
57.
2011
-
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan..
56.
2011
-
Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study..
57.
2011
-
Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary glands..
57.
2011
-
Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia..
58.
2011
-
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group..
55.
2010
-
Education and employment status of children and adults with thalassemia in North America..
55.
2010
-
Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia..
56.
2010
-
High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma..
55.
2010
-
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma..
55.
2010
-
Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma..
55.
2010
-
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia..
54.
2010
-
Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system..
54.
2010
-
Trilateral retinoblastoma: potentially curable with intensive chemotherapy..
54.
2010
-
Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study..
54.
2010
-
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience..
53.
2009
-
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG..
53.
2009
-
Familial retinoblastoma in developing countries..
53.
2009
-
Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study..
53.
2009
-
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma..
53.
2009
-
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab..
52.
2009
-
Vancomycin-resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection..
52.
2009
-
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group..
51.
2008
-
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors..
51.
2008
-
A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation..
50.
2008
-
Brain-sparing radiotherapy for neuroblastoma skull metastases..
50.
2008
-
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols..
50.
2008
-
The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue..
50.
2008
-
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy..
50.
2008
-
Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study..
50.
2008
-
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue..
50.
2008
-
Impairments in antifolate transport are common in retinoblastoma tumor samples..
50.
2008
-
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group..
50.
2008
-
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience..
50.
2008
-
Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines..
50.
2008
-
Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine..
50.
2008
-
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group..
49.
2007
-
A phase II trial of carboplatin for intraocular retinoblastoma..
49.
2007
-
Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients..
49.
2007
-
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies..
49.
2007
-
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors..
49.
2007
-
Factors associated with health-related quality of life in pediatric cancer survivors..
49.
2007
-
Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma..
49.
2007
-
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma..
49.
2007
-
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue..
49.
2007
-
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy..
48.
2007
-
A proposal for an international retinoblastoma staging system..
47.
2006
-
Pediatric surface osteosarcoma: clinical, pathologic, and radiologic features..
47.
2006
-
More aggressive bone marrow screening in retinoblastoma patients is not indicated: the memorial Sloan-Kettering cancer center experience..
46.
2006
-
Prognostic value of MYCN and ID2 overexpression in neuroblastoma..
45.
2005
-
Long-term complications in survivors of advanced stage neuroblastoma..
45.
2005
-
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia..
45.
2005
-
Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach..
43.
2004
-
Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia..
42.
2004
-
Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood..
42.
2004
-
High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors..
42.
2004
-
The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience..
42.
2004
-
Polycythemia vera in a 2-year-old child with a JAK2 exon 12 deletion..
68.
2021
-
An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy..
67.
2020
-
SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the pandemic..
67.
2020
-
Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major..
62.
2015
-
Antibody induced pain in children: An opportunity to study pain mechanism, IgG design and analgesics..
62.
2014
-
Health promotion for adolescent leukemia survivors.
2012
-
Induction for high-risk neuroblastoma.
2007
-
Treatment reduction for neuroblastoma.
2004
-
Dexamethasone swish and spit: A cause of iatrogenic adrenal insufficiency.
2024
-
Delirium in a patient with trisomy 21 undergoing chemotherapy for high-risk acute lymphoblastic leukemia.
2022
-
De novo antiphospholipid antibody syndrome in two infants.
2022
-
COVID-19 disease in New York City pediatric hematology and oncology patients.
2020
-
Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
2016
-
Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma.
2009
-
Why do young people get cancer?
2020
-
Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.
2017
-
Imaging and management of fetuses and neonates with alloimmune thrombocytopenia.
2017
-
Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8.
2015
-
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.
2015
-
ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.
2014
-
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.
2013
-
Strategies to manage retinoblastoma in developing countries.
2010
-
Sleep interventions in pediatric oncology: A systematic review of the evidence.
2024
-
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.
2024
-
Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young?
2024
-
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations.
2024
-
Advances in the clinical management of high-risk Wilms tumors.
2023
-
Pediatric refractory immune thrombocytopenia: A systematic review.
2022
-
The tumor microenvironment and immune targeting therapy in pediatric renal tumors.
2022
-
Sickle cell in Latin America and the United States [corrected].
2015
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)